IDA only vs Libya: Cause of death, by non-communicable diseases, ages 0-4, male
IDA only
8.1%
in 2021
Libya
41.5%
in 2021
IDA only rank
36th
Libya rank
36th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- IDA only
- Libya
How they compare
Libya currently reports 41.5% against 8.1% in IDA only, a difference of 33.4%.
That makes Libya's figure about 5.2 times IDA only's.
Across all 6 years both countries report, Libya has been ahead every year.
IDA only ranks 36th and Libya ranks 36th of 47 groups.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA only | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 28.3% | 23.8% | Libya |
| 2010s | 7.4% | 38.9% | 31.5% | Libya |
| 2020s | 8.1% | 41.3% | 33.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, IDA only or Libya?
- Libya, at 41.5% against 8.1% in IDA only as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between IDA only and Libya?
- 33.4%, with Libya ahead.
- How many years of comparable data are there for IDA only and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA only and Libya rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- IDA only ranks 36th and Libya ranks 36th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.